Project Grant T32GM153123
- Federal Project Grant Award Summary The University of Colorado Anschutz Medical Campus received a $340,192 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective July 11, 2025, through June 30, 2030. This predoctoral training grant supports the Pharmacology and Molecular Medicine Training Program (PHARMM), which provides five years of annual support for eight predoctoral students...
- Federal Project Grant Award Summary Case Western Reserve University (CWRU) received a $426,360 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective July 1, 2025, through June 30, 2030. The award funds the Molecular Pharmacology Training Program (MPTP), an interdisciplinary predoctoral training initiative designed to develop innovative PhD-level scientists with strong foundations in...
- Yale University received a $426,360 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to establish and operate the Yale Pre-Doctoral Pharmacology Training Program (PPTP). The award, effective July 1, 2025, through June 30, 2030, supports the development and delivery of an innovative graduate training curriculum designed to prepare diverse doctoral students for research careers in academia,...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the Regents of the University of Minnesota $306,474 under the Biomedical Research and Research Training program (CFDA 93.859) to support the Molecular Pharmacology and Therapeutics (MPAT) graduate program. The award, effective July 10, 2025, through June 30, 2030, funds support for five students per year during the initial two years of the program. The MPAT program delivers comprehensive...
- Federal Project Grant Award Summary The University of Pennsylvania received a $534,450 Predoctoral Training Grant in Pharmacology from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective July 1, 2025, through June 30, 2030. This award supports an interdisciplinary graduate training program designed to prepare doctoral students in the Pharmacology Graduate Group (PGG) for careers in academia, industry,...
- Federal Project Grant Award Summary Boston University Medical Campus received a $426,360 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 15, 2025, through June 30, 2030. The award supports the Predoctoral Training Program in Biomolecular Pharmacology, which provides comprehensive research training and career development to doctoral students pursuing advanced degrees...
- The Icahn School of Medicine at Mount Sinai (ISMMS) received a $331,270 Project Grant awarded on July 15, 2025, by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The grant funds the Integrated Training in Pharmacological Sciences (ITPSP) program, a predoctoral training initiative designed to develop highly skilled biomedical scientists in pharmacological research. Operating through June 30, 2030, ITPSP will...
- Summary of Federal Project Grant Award The National Institute of General Medical Sciences (NIGMS) awarded the University of Maryland, Baltimore a $416,240 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to support an established training program in cellular and molecular membrane biology. The award, made on August 18, 2025, with a completion date of June 30, 2030, funds an interdisciplinary training initiative now in its fourth decade that prepares...
- Federal Grant Award Summary The University of Washington received a $352,624 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 21, 2025, with completion targeted for June 30, 2030. This award funds a Pre-Doctoral Pharmacological Sciences Training Program (PSTP) that provides cross-disciplinary PhD-level training in pharmaceutical sciences by integrating research and...
- Federal Grant Award Summary The Cellular and Molecular Biology (CMB) Training Program at The Leland Stanford Junior University received a $1.6 million Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award, dated August 15, 2025, with a completion date of June 30, 2030, supports a comprehensive graduate student training initiative that has successfully mentored over 1,700 trainees...
CELLULAR AND MOLECULAR PHARMACOLOGY TRAINING PROGRAM - PROJECT SUMMARY THE PHARMACOLOGICAL SCIENCES TRAINING PROGRAM, RENAMED THE CELLULAR AND MOLECULAR PHARMACOLOGY (CMP) TRAINING PROGRAM IN THIS NEW SUBMISSION, IS ONE OF THE OLDEST AND LARGEST PHARMACOLOGY TRAINING PROGRAMS IN THE NATION. THE PROGRAM PROVIDES A SPECIFIC SET OF SKILLS AND A STRONG IDENTIFICATION WITH THE FIELD OF PHARMACOLOGY TO STUDENTS ENTERING THROUGH THE UMBRELLA BIOMEDICAL SCIENCES (BMS) PROGRAM AT UCSD. THE TRAINING PROGRAM IS ASSOCIATED WITH ONE OF THE PREMIER DEPARTMENTS OF PHARMACOLOGY, WHOSE FACULTY ARE HIGHLY FUNDED, DEDICATED TO GRADUATE EDUCATION, AND TRAINED AND EXPERIENCED MENTORS. JUNIOR FACULTY AND THOSE FROM OTHER UCSD DEPARTMENTS AND THE SKAGGS SCHOOL OF PHARMACY AND PHARMACEUTICAL SCIENCES COMPLEMENT THE LIST OF PHARMACOLOGY DEPARTMENT TRAINING MENTORS TO PROVIDE DIVERSE AND INTERDISCIPLINARY RESEARCH OPPORTUNITIES. STUDENTS JOIN THE CMP TRAINING PROGRAM AT THE BEGINNING OF THEIR SECOND YEAR OF GRADUATE WORK, HAVING TAKEN THE FIRST YEAR OF REQUIRED BMS DIDACTIC COURSES AND SEMINARS THAT COVER A BROAD RANGE OF STATE-OF-THE-ART RESEARCH AREAS, AND EMPHASIZE PRESENTATION AND COMMUNICATION SKILLS, QUANTITATIVE SKILLS, ETHICS, AND RIGOR AND REPRODUCIBILITY. THE ENTIRE CLASS OF FIRST YEAR BMS STUDENTS (~30 TRAINING GRANT ELIGIBLE STUDENTS) ARE INVITED TO APPLY TO THE CMP TRAINING PROGRAM AND MANY DO SO BECAUSE OF THE EXCELLENT REPUTATION OF THE PROGRAM AND ITS FACULTY. AT PRESENT THERE ARE 38 STUDENTS IN THE CMP TRAINING PROGRAM, WITH 7-8 STUDENTS ENTERING EACH YEAR AND SUPPORTED FOR TWO YEARS, CORRESPONDING TO THE REQUESTED 15 TRAINING GRANT SLOTS PER YEAR. ONCE IN THE PROGRAM, THE STUDENTS BECOME A HIGHLY COHESIVE GROUP THROUGH THEIR INTERACTIONS IN ADDITIONAL CMP-SPECIFIC CLASSES AND INTERDISCIPLINARY TRAINING EXPERIENCES. THESE INCLUDE AN INTRODUCTORY WORKSHOP IN THE FUNDAMENTALS OF RIGOR AND REPRODUCIBILITY, TWO COURSES IN DRUGS AND DISEASE, COMPUTATIONAL AND/OR QUANTITATIVE COURSES, A BIANNUAL CAREERS COURSE, A STUDENT ORGANIZED JOURNAL CLUB, ATTENDANCE AND PARTICIPATION IN THE WEEKLY RESEARCH DISCUSSION PRESENTATIONS, AND A YEARLY RETREAT FOCUSED IN LARGE PART ON THE TRAINEES. THROUGH THESE ACTIVITIES, THE PROGRAM SEEKS TO BUILD A DIVERSE POOL OF RIGOROUSLY TRAINED SCIENTISTS, WITH THE SKILLS REQUIRED FOR LEADERSHIP ROLES IN AREAS OF BIOMEDICAL SCIENCE WHERE TRAINING IN THE FUNDAMENTAL DISCIPLINE OF PHARMACOLOGY IMPACTS BASIC RESEARCH, DRUG DISCOVERY, PUBLIC POLICY AND EDUCATION. INTENDED AND REALIZED OUTCOMES, EVIDENCED BY THOSE OF OUR EXTENSIVE POOL OF ALUMNI, INCLUDE POSITIONS IN THE PHARMACEUTICAL AND BIOTECH INDUSTRY, IN GOVERNMENT AND REGULATORY AFFAIRS, IN PUBLIC POLICY AND SECONDARY EDUCATION, IN LAW, AND IN BIOMEDICAL AND PHARMACOLOGY EDUCATION. CRITICAL AND INDEPENDENT THINKING THAT PUSHES THE BOUNDARIES OF PHARMACOLOGICAL SCIENCE IS EMPHASIZED AND RECOGNIZED THROUGH A VARIETY OF AWARDS TO STUDENTS AND ALUMNI. IMPORTANTLY, WE MODEL INCLUSIVENESS THROUGH THE SIGNIFICANT FRACTION OF TRAINING FACULTY AND TRAINEES WHO ARE URMS AND WOMEN.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $370.4k | 7/11/25 | ||
| Not listed | $575.3k | 6/11/24 |